# BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

> **NCT00406601** · PHASE2 · COMPLETED · sponsor: **Istituto Clinico Humanitas** · enrollment: 69 (actual)

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** Sorafenib (BAY-43-9006)

## Key facts

- **NCT ID:** NCT00406601
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-09
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2010-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406601, "BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00406601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*